Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Edasalonexent (CAT-1004) is an orally available NF-κB inhibitor for the improvement of Duchenne muscular dystrophy.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 23,000 | |||
2 mg | 在庫あり | ¥ 34,000 | |||
5 mg | 在庫あり | ¥ 57,000 | |||
10 mg | 在庫あり | ¥ 91,000 | |||
25 mg | 在庫あり | ¥ 163,500 | |||
50 mg | 在庫あり | ¥ 257,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 61,500 |
説明 | Edasalonexent (CAT-1004) is an orally available NF-κB inhibitor for the improvement of Duchenne muscular dystrophy. |
In vitro | Edasalonexent effectively inhibits the pathogenic NF-κB subunit p65/RelA in vitro[3]. |
In vivo | In vivo, Edasalonexent effectively improves the phenotype of mdx mice in terms of activity, muscle mass and function, injury, inflammation, fibrosis, and cardiac pathology associated with voluntary wheel running[3]. |
別名 | CAT-1004 |
分子量 | 490.68 |
分子式 | C31H42N2O3 |
CAS No. | 1204317-86-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (163.04 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Edasalonexent 1204317-86-1 NF-Κb NF-κB CAT1004 CAT 1004 CAT-1004 Inhibitor inhibitor inhibit